Foley Hoag LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Headquartered in Boston, the licensing and strategic transactions team at Foley Hoag LLP is well-equipped to handle complex licensing arrangements across the healthcare and life sciences industries. The team also represents academic institutions and global companies on licensing and collaboration matters, advising on leading innovations in highly regulated markets. The team operates under the joint leadership of Boston-based Sarah Cooleybeck, who leads cross-border transactions and license agreements in the oncology, antibody, and pharmaceutical sectors; Boston-based John Harre, who works on drafting and executing complex mergers and acquisitions and licensing agreements in the life sciences, technology, and energy industries; and New York-based Sumantha Sedor, who advises leading life sciences companies from discovery through to commercialization.
Legal 500 Editorial commentary
Key clients
- LigaChem Biosciences
- Alloy Therapeutics
Work highlights
Advised LigaChem Biosciences on two licensing transactions with Ono Pharmaceutical, including an exclusive license to pre-clinical ADC LCB97 and a research collaboration and license leveraging LigaChem’s ConjuALL platform.


